Suppr超能文献

极低碳水化合物生酮饮食可改善 ob/ob 小鼠的葡萄糖耐量,而与体重减轻无关。

A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss.

机构信息

Division of Endocrinology, Beth Israel Deaconess Medical Center, Center for Life Sciences, 7th Fl., 330 Brookline Ave., Boston, MA 02215, USA.

出版信息

Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1197-204. doi: 10.1152/ajpendo.00357.2009. Epub 2009 Sep 8.

Abstract

In mice of normal weight and with diet-induced obesity, a high-fat, low-carbohydrate ketogenic diet (KD) causes weight loss, reduced circulating glucose and lipids, and dramatic changes in hepatic gene expression. Many of the effects of KD are mediated by fibroblast growth factor 21 (FGF21). We tested the effects of KD feeding on ob/ob mice to determine if metabolic effects would occur in obesity secondarily to leptin deficiency. We evaluated the effect of prolonged KD feeding on weight, energy homeostasis, circulating metabolites, glucose homeostasis, and gene expression. Subsequently, we evaluated the effects of leptin and fasting on FGF21 expression in ob/ob mice. KD feeding of ob/ob mice normalized fasting glycemia and substantially reduced insulin and lipid levels in the absence of weight loss. KD feeding was associated with significant increases in lipid oxidative genes and reduced expression of lipid synthetic genes, including stearoyl-coenzyme A desaturase 1, but no change in expression of inflammatory markers. In chow-fed ob/ob mice, FGF21 mRNA was elevated 10-fold compared with wild-type animals, and no increase from this elevated baseline was seen with KD feeding. Administration of leptin to chow-fed ob/ob mice led to a 24-fold induction of FGF21. Fasting also induced hepatic FGF21 in ob/ob mice. Thus, KD feeding improved ob/ob mouse glucose homeostasis without weight loss or altered caloric intake. These data demonstrate that manipulation of dietary macronutrient composition can lead to marked improvements in metabolic profile of leptin-deficient obese mice in the absence of weight loss.

摘要

在正常体重的小鼠和饮食诱导肥胖的小鼠中,高脂肪、低碳水化合物的生酮饮食(KD)可导致体重减轻、循环葡萄糖和脂质减少以及肝基因表达的显著变化。KD 的许多作用是通过成纤维细胞生长因子 21(FGF21)介导的。我们测试了 KD 喂养对 ob/ob 小鼠的影响,以确定在瘦素缺乏的情况下,肥胖是否会继发于 KD 的代谢作用。我们评估了长期 KD 喂养对体重、能量平衡、循环代谢物、葡萄糖稳态和基因表达的影响。随后,我们评估了瘦素和禁食对 ob/ob 小鼠 FGF21 表达的影响。KD 喂养可使 ob/ob 小鼠的空腹血糖正常化,并在不减轻体重的情况下显著降低胰岛素和脂质水平。KD 喂养与脂质氧化基因的显著增加和脂质合成基因(包括硬脂酰辅酶 A 去饱和酶 1)的表达减少相关,但炎症标志物的表达没有变化。在 chow 喂养的 ob/ob 小鼠中,FGF21 mRNA 比野生型动物高 10 倍,并且在 KD 喂养时没有从这个升高的基线增加。给予 leptin 可使 chow 喂养的 ob/ob 小鼠的 FGF21 诱导增加 24 倍。禁食也可诱导 ob/ob 小鼠的肝 FGF21。因此,KD 喂养改善了 ob/ob 小鼠的葡萄糖稳态,而没有减轻体重或改变热量摄入。这些数据表明,饮食宏量营养素组成的改变可以导致缺乏瘦素的肥胖小鼠的代谢谱显著改善,而无需减轻体重。

相似文献

1
A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss.
Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1197-204. doi: 10.1152/ajpendo.00357.2009. Epub 2009 Sep 8.
2
Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet.
PLoS One. 2013 Jul 9;8(7):e69330. doi: 10.1371/journal.pone.0069330. Print 2013.
3
Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Endocrinology. 2012 Jan;153(1):69-80. doi: 10.1210/en.2010-1262. Epub 2011 Nov 8.
5
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.
6
Tbc1d1 deletion suppresses obesity in leptin-deficient mice.
Int J Obes (Lond). 2016 Aug;40(8):1242-9. doi: 10.1038/ijo.2016.45. Epub 2016 Mar 22.
7
Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.
Am J Physiol Gastrointest Liver Physiol. 2019 May 1;316(5):G653-G667. doi: 10.1152/ajpgi.00404.2018. Epub 2019 Mar 28.
9
Long-term ketogenic diet causes glucose intolerance and reduced β- and α-cell mass but no weight loss in mice.
Am J Physiol Endocrinol Metab. 2014 Mar 1;306(5):E552-8. doi: 10.1152/ajpendo.00453.2013. Epub 2014 Jan 7.
10
Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet.
Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G956-67. doi: 10.1152/ajpgi.00539.2010. Epub 2011 Mar 31.

引用本文的文献

1
Ketone metabolites in metabolic dysfunction-associated steatotic liver disease progression: optimizing keto-therapeutic strategies.
Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E290-E301. doi: 10.1152/ajpendo.00178.2025. Epub 2025 Jul 7.
2
FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression.
Cell Metab. 2025 Jul 1;37(7):1547-1567.e6. doi: 10.1016/j.cmet.2025.05.011. Epub 2025 Jun 16.
3
Ketogenic Diet in Steatotic Liver Disease: A Metabolic Approach to Hepatic Health.
Nutrients. 2025 Apr 4;17(7):1269. doi: 10.3390/nu17071269.
5
Dietary pattern and hepatic lipid metabolism.
Liver Res. 2023 Nov 29;7(4):275-284. doi: 10.1016/j.livres.2023.11.006. eCollection 2023 Dec.
6
The role of the glucagon-FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition.
Diabetes Obes Metab. 2025 Feb;27(2):885-898. doi: 10.1111/dom.16089. Epub 2024 Dec 1.
7
The gut microbiota changed by ketogenic diets contribute to glucose intolerance rather than lipid accumulation.
Front Endocrinol (Lausanne). 2024 Sep 27;15:1446287. doi: 10.3389/fendo.2024.1446287. eCollection 2024.
8
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD).
J Clin Med. 2024 Aug 17;13(16):4857. doi: 10.3390/jcm13164857.

本文引用的文献

2
Fibroblast growth factor 21 corrects obesity in mice.
Endocrinology. 2008 Dec;149(12):6018-27. doi: 10.1210/en.2008-0816. Epub 2008 Aug 7.
3
Evaluation of glucose homeostasis.
Curr Protoc Mol Biol. 2007 Jan;Chapter 29:Unit 29B.3. doi: 10.1002/0471142727.mb29b03s77.
4
Low-carbohydrate-diet score and risk of type 2 diabetes in women.
Am J Clin Nutr. 2008 Feb;87(2):339-46. doi: 10.1093/ajcn/87.2.339.
6
Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice.
Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E261-70. doi: 10.1152/ajpendo.00676.2007. Epub 2007 Nov 14.
7
PPARalpha is a key regulator of hepatic FGF21.
Biochem Biophys Res Commun. 2007 Aug 24;360(2):437-40. doi: 10.1016/j.bbrc.2007.06.068. Epub 2007 Jun 21.
10
Beneficial effects of ketogenic diet in obese diabetic subjects.
Mol Cell Biochem. 2007 Aug;302(1-2):249-56. doi: 10.1007/s11010-007-9448-z. Epub 2007 Apr 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验